Polarean Imaging (LSE:POLX) Notes Receivable: £0.00 Mil (As of Jun. 2025)


What is Polarean Imaging Notes Receivable?

Polarean Imaging LSE:POLX -20.00% Notes Receivable is £0.00 Mil as of Jun. 2025. The stock has 4 warning signs investors should review.

Polarean Imaging's Notes Receivable for the quarter that ended in Jun. 2025 was £0.00 Mil.

Polarean Imaging Notes Receivable Related Terms

Polarean Imaging Notes Receivable Historical Data

* Premium members only.

The historical data trend for Polarean Imaging's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polarean Imaging Notes Receivable Chart

Polarean Imaging Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Polarean Imaging Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Polarean Imaging Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of £0.00 Mil mean?
Polarean Imaging (LSE:POLX) has a Notes Receivable of £0.00 Mil as of Jun. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Polarean Imaging and its competitors.
Is Polarean Imaging's Notes Receivable too high?
Polarean Imaging's current Notes Receivable is £0.00 Mil.
How does Polarean Imaging's Notes Receivable compare to FOFA and BTCY?
Polarean Imaging's Notes Receivable of £0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Polarean Imaging and its competitors. Polarean Imaging's current Notes Receivable is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polarean Imaging stock overvalued right now?
Polarean Imaging (LSE:POLX) has a current Notes Receivable of £0.00 Mil. The current Notes Receivable is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Polarean Imaging (LSE:POLX), the current Notes Receivable is £0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Polarean Imaging Business Description

Address 27-28 Eastcastle Street, London, GBR, W1W 8DH
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment is the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives the majority of its revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service, and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.